Major COVID-19 vaccine trial resumes in UK after safety review
Pharma giant AstraZeneca and Oxford University on Saturday said they had resumed a COVID-19 vaccine trial after getting the all-clear from British regulators, following a pause caused by a UK volunteer falling ill. “Clinical trials for the AstraZeneca Oxford coronavirus vaccine, AZD1222, have resumed in the UK following confirmation by the Medicines Health Regulatory Authority (MHRA) that it was safe […]
» Read more